Amryt Pharma plc Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Joe Wiley, was filed 08 Mar 2021.
Amryt Pharma plc: what insiders have been doing
Amryt Pharma plc is a listed company. Its insiders report their share dealings to RNS (LSE). The past year has been quiet: not a single insider filing for Amryt Pharma plc. The previous disclosure was published on 8 March 2021.
Our records for Amryt Pharma plc go back to 2017, with 5 purchases and no sales on the open market in total.
These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
· cache
- 2,031,350 sharesOutside a trading venueISIN GB00BKLTQ412FCA-NSM:1000461039-en-0Canonical exit: 6 Jun 2021 (T+90)
- 1,400,000 sharesOutside a trading venueISIN GB00BKLTQ412FCA-NSM:1000461039-en-1Canonical exit: 6 Jun 2021 (T+90)
- 12,500 shares@ £1.4024.2% of flowLondon Stock Exchange (AIM)ISIN GB00BKLTQ412FCA-NSM:3616414Canonical exit: 1 Sept 2020 (T+90)
- 50,000 shares@ £1.1075.8% of flowLondon Stock Exchange (AIM)ISIN GB00BKLTQ412FCA-NSM:3614658Canonical exit: 18 Aug 2020 (T+90)
- 100,000 shares@ £0.215100.0% of flowLondon Stock Exchange, AIM Market (XLON)ISIN GB00BDD1LS57FCA-NSM:LSE20170410172152_13189904_20200330131459041_6977Canonical exit: 9 Jul 2017 (T+90)
5 of 5 declarations
About Amryt Pharma plc
Amryt Pharma plc is a biopharmaceutical company focused on developing treatments for rare diseases. It is listed on the London Stock Exchange.
